ABL, RDI Collaborate on HIV Management Tool | GenomeWeb

NEW YORK (GenomeWeb) – Advanced Biological Laboratories and the HIV Resistance Response Database Initiative (RDI) this week announced a collaboration on HIV management.

Under the agreement, data stored in ABL's health management system, TherapyEdge, can be automatically uploaded to RDI's HIV Treatment Response Prediction System (HIV-TRePS), allowing physicians to predict patient response to HIV drug combinations in seconds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.